[ad_1]
“The first 2-3 million doses of the vaccine against Covid Oxford-Irbm-AstraZeneca should arrive in Italy by the end of November if the ongoing trial progresses positively,” the president of Irbm Pomezia, who collaborated with the Jenner Institute of the University of Oxford in the development of the vaccine prototype
Piero di Lorenzo, president of the Pomezia Irbm that works on the coronavirus vaccine (LIVE UPDATES – THE SPECIAL) told Ansa that “the first 2-3 million doses of the Oxford-Irbm-AstraZeneca anti-Covid vaccine should to arrive in Italy at the end of November if the ongoing trial proceeds positively, after temporary suspension due to a suspicious reaction in a volunteer that proved to be unrelated to the candidate vaccine. “
“If there are no critical issues, respect the time announced by Speranza”
deepening
Coronavirus, exceeded 935 thousand deaths. Trump: vaccine in 3-4 weeks
The Pomezia Irbm is collaborating with the Jenner Institute of the University of Oxord in the development of the vaccine prototype. If there are no critical problems and the experimentation continues as planned, then “the time already announced by the Minister of Health, Roberto Speranza, will be respected, added Piero di Lorenzo.”
Resumption of testing after shutdown.
deepening
Covid-19, Oxford vaccine: AstraZeneca resumes testing in Britain
Meanwhile, AstraZeneca continues with tests in Great Britain, halted a few days ago due to the appearance of an undesirable effect in one of the participants. It was, as the Cambridge-based company explained, a “standard process that is activated whenever an unexpected clinical condition occurs during clinical development, which is investigated to ensure the integrity of study conduct.”
Esperanza: “With the vaccine we will win the game”
deepening
Influenza vaccines, State-Regions agreement approved
“There is unprecedented work in progress on the vaccine that will lead us to success. The man is going to win this match. Then we will see if it will be Astra Zeneca or another company, these are the words of the Minister of Health, Roberto Speranza to Porta a Porta – The truth is that we want the vaccine as soon as possible and we want it safe. We will never authorize a vaccine that has not completed all the steps on time ”. The minister then pointed out: “The Oxford vaccine is one of the seven vaccines the European Union is investing in. We have a total investment attitude because we believe that the vaccine is really a decisive match.”
